Piqray (200 Mg Daily Dose)
Piqray (200 MG Daily Dose) 28 Tablets Therapy Pack
¿Qué es Piqray (200 Mg Daily Dose)?
Piqray (alpelisib) de 200 mg diarios es un medicamento oral que se prescribe para el tratamiento del cáncer de mama avanzado o metastásico positivo a receptores hormonales, negativo a HER2 y con mutación en PIK3CA. Suele utilizarse en combinación con fulvestrant después de una progresión durante o después de un régimen basado en endocrinoterapia. Alpelisib destaca una ventaja de supervivencia al inhibir la fosfoinositida 3-quinasa (PI3K), una proteína clave en el crecimiento y la proliferación de las células cancerosas. Esta terapia dirigida se prescribe tras la identificación de la mutación PIK3CA específica mediante una prueba aprobada por la FDA.Side Effects
- Allergic reaction: Itching or hives, swelling in your face or hands, swelling or tingling in your mouth or throat, chest tightness, trouble breathing
- Blistering, peeling, red skin rash
- Increased thirst, hunger, or urination, weight loss
Warnings
- Pregnancy after menopause is not likely, but if you think you could be pregnant, tell your doctor. This medicine could harm an unborn baby. If you are a woman who can bear children, your doctor may give you a pregnancy test before you start using this medicine to make sure you are not pregnant. Women should use an effective form of birth control during treatment and for 1 week after the last dose. Male patients who have female partners should use effective birth control during treatment and for 1 week after the last dose.
- Do not breastfeed during treatment with this medicine and for 1 week after the last dose.
- Tell your doctor if you have kidney disease, lung disease or breathing problems, or diabetes.
- This medicine may cause the following problems:Serious skin reactions, including Stevens-Johnson syndrome, erythema multiforme, toxic epidermal necrolysis, and drug reaction with eosinophilia and systemic symptoms (DRESS)Lung or breathing problems (including pneumonitis, interstitial lung disease)
- This medicine may cause a high blood sugar level. Your doctor may give you metformin before starting treatment with this medicine.
Prescription savings · ·
¿Qué es Piqray (200 Mg Daily Dose) ?
Piqray (alpelisib) de 200 mg diarios es un medicamento oral que se prescribe para el tratamiento del cáncer de mama avanzado o metastásico positivo a receptores hormonales, negativo a HER2 y con mutación en PIK3CA. Suele utilizarse en combinación con fulvestrant después de una progresión durante o después de un régimen basado en endocrinoterapia. Alpelisib destaca una ventaja de supervivencia al inhibir la fosfoinositida 3-quinasa (PI3K), una proteína clave en el crecimiento y la proliferación de las células cancerosas. Esta terapia dirigida se prescribe tras la identificación de la mutación PIK3CA específica mediante una prueba aprobada por la FDA.Piqray (200 Mg Daily Dose) Cupones y Precios - Rx.com
Piqray (200 MG Daily Dose) 28 Tablets Therapy Pack
Medicamentos Relacionados
Browse more medications: starting with P · full A-Z directory · by condition · common drugs
Medical disclaimer: This information is provided for general educational purposes only and is not medical advice. It is not a substitute for professional diagnosis or treatment. Always consult a licensed physician, pharmacist, or other qualified healthcare provider before starting, stopping, or changing any medication or treatment. Never disregard professional medical advice or delay seeking it because of something you read here. If you think you may have a medical emergency, call your doctor or 911 immediately.